Skip to main content
. Author manuscript; available in PMC: 2020 Apr 2.
Published in final edited form as: Circulation. 2019 Apr 2;139(14):1698–1709. doi: 10.1161/CIRCULATIONAHA.118.036632

Table 3.

Association of mid-pregnancy placental growth factor in quartiles with cardiovascular risk factors six and nine years after pregnancy

Outcome Low PlGF
MoM ≤ 0.72
116.4 pg./mL
(62.6, 171.4)
Beta (95% CI)
Medium low PlGF
MoM 0.73 - 1.0
176.7 pg./mL
(127.6, 247.9)
Beta (95% CI)
Medium high PlGF
MoM 1.01 - 1.40
243.9 pg./mL
(176.5, 342.5)
Beta (95% CI)
High PlGF
MoM ≥ 1.41
422.2 pg./mL
(260.2, 714.8)
P for Trend Adjusted P-value
Total population (n = 3797)
Six years after pregnancy
   Aortic root diameter (mm) 0.40 (0.08, 0.73) 0.22 (−0.10, 0.54) 0.20 (−0.13, 0.52) ref <0.001 <0.001
   Left atrial diameter (mm) 0.34 (−0.09, 0.78) 0.26 (−0.17, 0.69) 0.40 (−0.03, 0.83) ref <0.001 <0.001
   Left ventricular mass (g) 4.6 (1.1, 8.1) 1.2 (−2.3, 4.6) 0.74 (−2.8, 4.2) ref <0.001 <0.001
   Pulse wave velocity (m/s) 0.01 (−0.13, 0.15) −0.09 (−0.23, 0.05) 0.02 (−0.12, 0.15) ref 0.33 0.61
   Fractional shortening −0.01 (−0.58, 0.55) −0.05 (−0.60, 0.50) 0.10 (−0.46, 0.66) ref 0.42 0.62
   Central retinal arteriolar caliber (SDS) −0.09 (−0.20, 0.03) −0.10 (−0.22, 0.01) −0.04 (−0.16, 0.08) ref 0.62 0.68
   Central retinal venular caliber (SDS) 0.04 (−0.08, 0.16) 0.04 (−0.07, 0.16) 0.02 (−0.10, 0.14) ref 0.86 0.86
   SBP (mmHg) 2.3 (0.93, 3.6) 1.0 (−0.31, 2.3) 1.3 (0.04, 2.7) ref 0.005 0.02
   DBP (mmHg) 0.89 (−0.15, 1.9) 0.63 (−0.40, 1.7) 1.2 (0.17, 2.2) ref 0.51 0.62
Nine years after pregnancy (n=3198)
   SBP (mmHg) 2.6 (1.2, 4.0) 1.2 (−0.21, 2.6) 2.2 (0.82, 3.6) ref 0.04 0.09
   DBP (mmHg) 1.8 (0.81, 2.7) 0.88 (−0.05, 1.8) 1.4 (0.48, 2.3) ref 0.46 0.62
Uncomplicated pregnancies (n=3270)
Six years after pregnancy
   Aortic root diameter (mm) 0.45 (0.09, 0.80) 0.33 (−0.02, 0.67) 0.30 (−0.05, 0.64) ref <0.001 <0.001
   Left atrial diameter (mm) 0.28 (−0.20, 0.75) 0.16 (−0.30, 0.62) 0.30 (−0.16, 0.76) ref <0.001 <0.001
   Left ventricular mass (g) 5.1 (1.3, 8.9) 2.2 (−1.5, 5.9) 1.2 (−2.5, 4.8) ref <0.001 <0.001
   Pulse wave velocity (m/s) 0.04 (−0.11, 0.19) −0.09 (−0.24, 0.06) 0.01 (−0.13, 0.16) ref 0.27 0.50
   Fractional shortening −0.12 (−0.72, 0.48) −0.15 (−0.73, 0.44) 0.21 (−0.38, 0.79) ref 0.41 0.56
   Central retinal arteriolar caliber (SDS) −0.08 (−0.21, 0.04) −0.09 (−0.21, 0.03) −0.04 (−0.16, 0.08) ref 0.57 0.68
   Central retinal venular caliber (SDS) 0.07 (−0.06, 0.20) 0.06 (−0.07, 0.19) 0.02 (−0.11, 0.15) ref 0.70 0.70
   SBP (mmHg) 1.8 (0.35,3.2) 0.67 (−0.71, 2.1) 0.78 (−0.59, 2.2) ref 0.003 0.008
   DBP (mmHg) 0.82 (−0.29, 1.9) 0.39 (−0.70, 1.5) 0.83 (−0.25, 1.9) ref 0.40 0.56
Nine years after pregnancy (n=2748)
   SBP (mmHg) 2.3 (0.84, 3.8) 0.78 (−0.70, 2.3) 1.9 (0.40, 3.3) ref 0.047 0.10
   DBP (mmHg) 1.6 (0.58, 2.6) 0.70 (−0.29, 1.7) 1.1 (0.17, 2.1) ref 0.62 0.68

Abbreviations: Body mass index, BMI ;Confidence Interval, CI; Diastolic blood pressure, DBP; Multiple of the median, MoM; Placental growth factor, PlGF; Systolic blood pressure, SBP; Standard deviation score, SDS. Values are regression coefficients with β and 95% confidence interval, based on linear regression models, and are compared to women with high PlGF. Estimates represent the unit increase in the outcome per 1 multiple of the median increase in PlGF, compared to the reference category.

Adjusted for maternal age at enrollment, gravidity during pregnancy, time interval between pregnancy and follow-up, ethnicity, educational level, smoking during pregnancy, change in systolic blood pressure between early pregnancy and mid-pregnancy (and change in BMI between pre-pregnancy and mid-pregnancy in the BMI model).

*

In addition to the ‡ model adjusted for pulse at the time of PWV assessment.

In addition to the ‡ model adjusted for other retinal vessel.

The P for trend is the result of univariate ANOVA analysis through linear contrast analysis. The adjusted P-value adjusts for multiple comparisons via the Benjamini-Hochberg method.